Background The consequences of infection with Staphylococcusaureus can be severe, so strategies for prevention are important.We examined S. aureus isolates from blood and from nasal specimensto determine whether the organisms in the bloodstream originatedfrom the patient's own flora.
Methods In a multicenter study, swabs for culture were obtainedfrom the anterior nares of 219 patients with S. aureus bacteremia.A total of 723 isolates were collected and genotyped. In a secondstudy, 1640 S. aureus isolates from nasal swabs from 1278 patientswere collected over a period of five years and then comparedwith isolates from the blood of patients who subsequently hadS. aureus bacteremia.
Results In the multicenter study of S. aureus bacteremia, theblood isolates were identical to those from the anterior naresin 180 of 219 patients (82.2 percent). In the second study,14 of 1278 patients who had nasal colonization with S. aureussubsequently had S. aureus bacteremia. In 12 of these 14 patients(86 percent), the isolates obtained from the nares were clonallyidentical to the isolates obtained from blood 1 day to 14 monthslater.
Conclusions A substantial proportion of cases of S. aureus bacteremiaappear to be of endogenous origin since they originate fromcolonies in the nasal mucosa. These results provide supportfor strategies to prevent systemic S. aureus infections by eliminatingnasal carriage of S. aureus.
Staphylococcus aureus is one of the most common causes of bothendemic and epidemic infections acquired in hospitals, whichresult in substantial morbidity and mortality. In U.S. hospitalsin the National Nosocomial Infections Surveillance system, S.aureus accounted for up to 13 percent of isolates recoveredfrom patients with nosocomial infections from 1979 through 1995,and the percentage has increased in recent years.1,2 Community-acquiredinfections with S. aureus are also common.2,3 Multidrug-resistantstrains of staphylococci have been reported with increasingfrequen-cy worldwide, including isolates that are resistantto methicillin, lincosamides, macrolides, aminoglycosides, fluoroquinolones,or combinations of these antibiotics.3,4 Because glycopeptidesare the main drugs with reliable activity against methicillin-resistantstrains of S. aureus, the emergence of S. aureus strains withintermediate resistance to glycopeptides has aroused concernabout the development of strains resistant to all availableantibiotics.5 The severe consequences of infection with S. aureusheighten the importance of prevention. Colonized patients arethe chief source of S. aureus in hospitals.1,6 Approximately10 to 40 percent of people tested as outpatients or on admissionhave nasal carriage of S. aureus.7,8 Colonizing strains mayserve as endogenous reservoirs for overt clinical infectionsor may spread to other patients. Several studies have shownthat elimination of carriage in the anterior nares, the principalreservoirs of S. aureus, reduces the incidence of S. aureusinfections.6,9,10,11,12,13 However, previous studies did notsystematically investigate the link between S. aureus isolatedfrom blood and S. aureus isolated from nasal specimens, takenbefore and after bacteremia was detected, with the use of modernmolecular methods. Therefore, we undertook this study to assessthe correlation between strains colonizing the anterior naresand strains in the blood of patients with S. aureus bacteremia.
Methods
Study Design
To investigate the correlation between S. aureus isolates fromthe anterior nares and S. aureus isolates from blood, two approacheswere used. First, in a multicenter study performed from November1993 to September 1994, which comprised general and intensivecare units of 32 university and community hospitals in Germany,swabs were obtained from the anterior nares of patients withS. aureus bacteremia and cultured. As defined by the protocol,the nasal cultures were obtained immediately after the isolationof S. aureus from the blood. All isolates, including those fromfoci of infection as judged on clinical grounds, were sent toone center (the University of Münster) for genotyping.In addition, each patient's physician completed a case-recordform. The completed forms were sent to the Biometrics Departmentof SmithKline Beecham, Munich, for statistical analysis. Informationcollected in the case-record forms included data that identifiedthe patient (initials, date of birth, and patient identificationnumber); location in the hospital (general ward, specializedward, or intensive care unit); the dates when blood cultures,nasal swabs, and other clinical specimens that showed growthof S. aureus were obtained; and the clinically presumed focusof S. aureus bacteremia.
Identification of S. aureus was based on conventional criteria(including the coagulase tube test and the API Staph system[ATB32 Staph, BioMérieux, Marcy-l'Etoile, France]). Inaddition, all isolates of uncertain identity were confirmedas S. aureus by testing for the S. aureusspecific nucgene by the polymerase chain reaction.14 If nasal colonizationwith S. aureus was detected, all strains, including those isolatedfrom presumed foci of infection, were collected and characterizedby pulsed-field gel electrophoresis.
In a second study, performed from June 1994 to June 1999, S.aureuspositive cultures of swabs from the anterior nareswere collected prospectively at a single center in Münster,a 1568-bed tertiary-care hospital with five intensive care units,three of which were for surgical patients. The cultured specimenswere obtained over a period of five years from patients in generalwards as well as from patients in intensive care units duringroutine surveillance and were then frozen. These S. aureus isolateswere also compared by pulsed-field gel electrophoresis withS. aureus isolates from the blood of patients in whom bacteremiasubsequently developed during the same hospital stay or a laterone at the University of Münster.
Pulsed-field gel electrophoresis was performed in one center(the University of Münster), as previously described.15Strains isolated from an individual patient were randomly placedon the same gel. They were considered clonally identical ifno differences in the band pattern were observed.16
Whether the isolates were resistant to methicillin was determinedon MuellerHinton agar (Difco, Augsburg, Germany) supplementedwith 2 percent sodium chloride (after incubation for 48 hoursat 30°C) and was confirmed by testing for the mecA geneby the polymerase chain reaction, as previously described.17To test for resistance to methicillin, in general, only oneisolate from each patient was studied. If one patient had clonallydifferent strains, the other strains were also tested. The multicenterstudy was approved by the ethics committee of our institution,and oral informed consent was obtained from all participatingpatients.
Statistical Analysis
Demographic characteristics were compared with the use of Fisher'sexact test (two-tailed) and the Wilcoxon two-sample test. Statisticalcalculation of the 95 percent confidence intervals for binomialproportions was performed with the SAS statistical program (version6.12, SAS Institute, Cary, N.C.). The confidence interval forthe difference between two proportions was calculated accordingto the methods of Wallenstein.18 All reported P values are two-sided.
Results
In this study, pulsed-field gel electrophoresis, an establishedmethod of molecular typing, was used to compare colonizing S.aureus strains isolated from the anterior nares, strains isolatedfrom the blood in patients with S. aureus bacteremia, and strainsisolated from the clinically presumed focus of infection. Atotal of 723 S. aureus strains, isolated from 219 patients (meanage, 54.7 years), were included in the multicenter study. Sampleswere obtained from patients in general care units (55 percent),intensive care units (27 percent), oncology or hematology units(7 percent), and other units (11 percent). Patients were mostcommonly hospitalized in internal-medicine units (59 percent)and surgical units (21 percent). A total of 219 strains wereisolated from the blood, 350 from the anterior nares, and 154from other clinical specimens. These specimens were obtainedprimarily from skin, mucous membranes, and soft tissue (48 percent);from short-term or long-term catheters (27 percent); and fromthe respiratory tract (15 percent).
The most common causes of the S. aureus bacteremia, as judgedon clinical grounds, were catheter-related infections (in 46percent of patients); osteomyelitis or skin and soft-tissueinfections such as cutaneous abscesses and cutaneous ulcerations(in 27 percent); and infections of the lower respiratory tract(in 11 percent) (Figure 1).
Figure 1. Presumed Causes of the S. aureus Bacteremia in 156 Patients, on the Basis of Clinical Evidence.
Twenty of the 219 patients (9.1 percent) harbored methicillin-resistantstrains, of nine different genotypes. Twenty-six methicillin-susceptiblestrains, obtained from three hospitals in which no methicillin-resistantstrains were isolated from blood during the study, were comparedwith one another; these strains were all clonally different.
For most of the strains, the isolates from the blood were identicalto those from the anterior nares of the same patients (180 of219 [82.2 percent; 95 percent confidence interval, 76.4 to 87.1percent]), as well as to those from areas other than the nares(94.3 percent); identity was determined according to stringentcriteria for the evaluation of the band pattern revealed bypulsed-field gel electrophoresis. These results did not varysignificantly according to the time between sample collectionsin cases in which nasal swabs were obtained after the onsetof bacteremia (Table 1).
Table 1. Distribution of Identical and Nonidentical Pairs of S. aureus Isolates Stratified According to the Time between the Onset of Bacteremia and the Subsequent Collection of Nasal Swabs in 219 Patients.
In the second study, conducted at a single institution, 1640S. aureus strains were isolated from nasal swabs from 1278 patientsduring a five-year period. In 74 of these patients (5.8 percent),methicillin-resistant strains of 34 different genotypes wereisolated from the anterior nares. In 14 of the patients whohad nasal colonization, including 1 with a methicillin-resistantstrain, S. aureus bacteremia subsequently developed. These ninefemale and five male patients (median age, 35 years; range,4 to 79) had a broad range of diseases and were hospitalizedin nine different units, including general care as well as intensivecare units specializing in internal medicine, pediatrics, surgery,neurosurgery, and neurology. There were no significant differencesbetween these 14 patients and the other 258 patients in whomS. aureus bacteremia developed at the University of Münsterduring the five-year period with respect to age (median, 53.5years; range, 1 to 86) or sex (103 female and 155 male patients).With regard to the proportion with methicillin-resistant strains,the rate of resistance was similar in the patients in whom S.aureus had previously been isolated from the anterior nares(1 of 14 patients [7 percent]) and in all other patients withS. aureus bacteremia (9 of 258 patients [3.5 percent]). Themethicillin-resistant strains isolated from blood representedsix different genotypes.
In 12 of the 14 patients who had nasal colonization and in whomS. aureus bacteremia subsequently developed (85.7 percent),strains isolated from the anterior nares days or months earlierwere clonally identical to the strains later isolated from theblood. In these patients, S. aureus isolates from nasal swabsthat were clonally identical to the isolates from blood wereobtained from six patients within 1 week before the onset ofbacteremia, from three additional patients within 1 month beforeonset, and from three further patients more than 3 months beforeonset (median time, 6.5 days) (Table 2). Only two patients withS. aureus bacteremia had nasal colonization with a clonallydifferent strain of S. aureus before the bacteremia developed.Figure 2 shows the results of pulsed-field gel electrophoresiswith selected isolates.
Table 2. Distribution of Identical and Nonidentical Pairs of S. aureus Isolates Stratified According to the Time between the Collection of Nasal Swabs and the Subsequent Onset of Bacteremia in 14 Patients.
Figure 2. Results of Pulsed-Field Gel Electrophoresis of Selected S. aureus Isolates Obtained from Nasal Swabs (Lanes 1, 3, 5, 7, 9, 11, and 13) and Subsequently from the Blood (Lanes 2, 4, 6, 8, 10, 12, and 14) of Seven Patients.
The intervals between sample collections are indicated in parentheses. DNA fragments were separated after digestion with Sma I. Lanes 1 and 2 show the results for Patient 1 (1 day); lanes 3 and 4, for Patient 2 (3 days); lanes 5 and 6, for Patient 3 (3 days); lanes 7 and 8, for Patient 4 (2 weeks); lanes 9 and 10, for Patient 5 (2 weeks); lanes 11 and 12, for Patient 6 (31 weeks); and lanes 13 and 14, for Patient 7 (60 weeks). The denotes the molecular size marker. In all patients except Patients 3 and 4, nasal and blood isolates were clonally identical.
The proportion of patients who had nasal colonization by S.aureus before clonally identical strains of S. aureus were detectedin the blood was 85.7 percent (95 percent confidence interval,57.1 to 98.2 percent). The 95 percent confidence interval forthe 3.5 percentage point difference in this proportion betweenthe two parts of our study (82.2 percent in the first, multicenterstudy and 85.7 percent in the second, five-year study) was 22.4to 14.7 percent. Thus, the results of the multicenter studydemonstrating that nasal and blood isolates are clonally identicalin about 82 percent of patients with S. aureus bacteremia wereconfirmed by the second study, in which about 86 percent ofthe patients were colonized in the anterior nares by the sameclone that was subsequently isolated from the blood. Hence,it can be stated with 95 percent confidence that at least 50percent of the patients with S. aureus bacteremia were firstcolonized in the anterior nares by an identical strain.
Discussion
The anterior nares are reservoirs for S. aureus. Mucin appearsto be the critical surface that is colonized in a process involvinginteractions between staphylococcal protein and mucin carbohydrate.19The role of interference by other commensal bacteria, secretoryIgA, or specific staphylococcal adhesins is unknown. Three patternsof carriage can be distinguished, although the criteria usedto identify these patterns have been inconsistent.1,8,20 First,approximately 20 percent of healthy people almost always carrya strain. Second, a large proportion of the population (approximately60 percent) harbors S. aureus intermittently, and the strainschange with varying frequency. Third, only a minority of people(approximately 20 percent) almost never carry S. aureus.1,8,21Persistent carriage is more common in children than in adults,and the carrier type changes in many people between the agesof 10 and 20 years.22
Carriage of S. aureus in the nose appears to play a key partin the pathogenesis of infection. Nasal carriage has been associatedwith an increased risk of infection in patients after surgery,in patients receiving continuous ambulatory peritoneal dialysis,and in patients receiving hemodialysis.6,7,13,23,24 In a studyof the epidemiology of S. aureus infections in patients receivinghemodialysis, Ena et al. investigated 12 infections in threepatients and reported that 11 of these infections were causedby isolates previously identified in surveillance studies.25Luzar reported that 45 percent of the patients she studied werenasal carriers before catheters were inserted. Catheter exit-siteinfections occurred at a rate of 0.4 episode per patient peryear in carriers but less frequently in noncarriers (0.1 episodeper patient per year).26 Nasal carriage of S. aureus was a riskfactor for the development of nosocomial bacteremia during anoutbreak of methicillin-resistant S. aureus in an intensivecare unit, with rates of bacteremia of 38 percent for carriersof methicillin-resistant strains, 9.5 percent for carriers ofsusceptible strains, and 1.7 percent for noncarriers.27
In several studies, the elimination of nasal carriage reducedthe incidence of S. aureus infections.10,12,13,28 Kluytmanset al. observed a significant reduction in the rate of surgical-woundinfection after intervention with mupirocin nasal ointment.9Nasal treatment with mupirocin led to a reduction by a factorof four in the incidence of S. aureus bacteremia per patient-year(from 0.097 to 0.024 episode) in carriers receiving hemodialysis.11When the nares were treated topically to eliminate nasal carriage,S. aureus usually disappeared from other areas of the body.29,30,31In patients receiving hemodialysis, 87 percent of those whocarried S. aureus in their nares and on their hands carriedthe same strain at both sites.30 Treatment with topical mupirocin,which eliminates nasal carriage, also eliminates hand carriage.29The proposed mechanism of pathogenesis for a number of endogenousinfections is the colonization of the skin from the anteriornares, which causes subsequent infection in patients with areasof impaired skin, such as patients receiving dialysis and patientswith intravascular catheters.
Although nasal carriage of S. aureus has been suggested as thesource of subsequent infections, previous studies were limitedto single hospitals23,24,25,27,28,32 or to defined patient groups such as patients receiving hemodialysis,10,12,13,25patients in intensive care units,23,27,32 or patients infectedwith the human immunodeficiency virus24,33 or they wereperformed in the setting of an outbreak with methicillin-resistantstrains.27,32 In addition, in most studies, typing systems ofhigh discriminatory power were not systematically used to showthat the strain colonizing the anterior nares was identicalto the strain from the focus of infection, the strain from theblood, or both and thus to support the hypothesis that S. aureusbacteremia is of endogenous origin.7,9,10,11,12,13,24,25,28
Modern methods of molecular typing, which have high discriminatorypower and which differentiate among strains isolated from multiplesources in one patient, are essential to studies of the originof S. aureus bacteremia.34,35 We systematically used pulsed-fieldgel electrophoresis in a large multicenter study to determinewhether there was identity between S. aureus strains isolatedfrom blood and those isolated from the anterior nares beforeand after the detection of bacteremia. In the large majorityof patients with S. aureus bacteremia, the isolate from bloodwas identical to that from the anterior nares. Strains isolatedfrom blood cultures and from nasal-swab cultures were clonalin 82.2 percent and 85.7 percent of patients, as shown by pulsed-fieldgel electrophoresis in the two studies. Thus, a substantialproportion of cases of bacteremia may be caused by endogenousstrains of S. aureus.
In summary, in patients with S. aureus bacteremia there is astrong correlation between strains colonizing the anterior nares,strains isolated from foci of infection, and strains isolatedfrom blood, suggesting that S. aureus bacteremia may have anendogenous origin. Our results provide evidence that strategiesto interrupt transmission of S. aureus by the elimination ofnasal carriage may prevent systemic S. aureus infections.
Supported by a grant from SmithKline Beecham, Munich, Germany,and conducted under the auspices of the Paul Ehrlich Society(Staphylococcus Working Group) and the German Society for Hygieneand Microbiology (Hospital Hygiene Working Group).
We are indebted to A. Heinecke and W. Köpke at the Institutefor Medical Informatics and Biomathematics, University of Münster,for statistical advice; to M. Herrmann and B. Sinha for helpfuldiscussions; and to M. Brück, U. Hörling, S. Weber,and M. Schulte for expert technical assistance.
* Participants in the study group are listed in the Appendix.
Source Information
From the Institute of Medical Microbiology, University of Münster, Münster (C.E., K.B., G.P.); and SmithKline Beecham, Munich (K.M., H.S.) both in Germany.
Address reprint requests to Dr. von Eiff at the Institute of Medical Microbiology, Westf älische Wilhems-Universität Münster, Domagkstr. 10, 48149 Münster, Germany, or at eiffc{at}uni-muenster.de.
References
Boyce JM. Epidemiology and prevention of nosocomial infections. In: Crossley KB, Archer GL, eds. The staphylococci in human disease. New York: Churchill Livingstone, 1997:309-29.
Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996;23:255-259. [ISI][Medline]
Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520-532. [Free Full Text]
Moellering RC Jr. Problems with antimicrobial resistance in gram-positive cocci. Clin Infect Dis 1998;26:1177-1178. [ISI][Medline]
Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999;340:493-501. [Free Full Text]
Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 1995;31:13-24. [CrossRef][ISI][Medline]
Kluytmans JA, Mouton JW, Ijzerman EP, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995;171:216-219. [ISI][Medline]
Williams REO. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963;27:56-71. [Free Full Text]
Kluytmans JA, Mouton JW, VandenBergh MF, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996;17:780-785. [ISI][Medline]
Chow JW, Yu VL. Staphylococcus aureus nasal carriage in hemodialysis patients: its role in infection and approaches to prophylaxis. Arch Intern Med 1989;149:1258-1262. [Abstract]
Boelaert JR, Van Landuyt HW, Godard CA, et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 1993;8:235-239. [Free Full Text]
Holton DL, Nicolle LE, Diley D, Bernstein K. Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic haemodialysis patients. J Hosp Infect 1991;17:133-137. [CrossRef][ISI][Medline]
Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med 1986;315:91-96. [Abstract]
Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol 1992;30:1654-1660. [Free Full Text]
Maslow JN, Slutsky AM, Arbeit RD. Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular microbiology: principles and applications. Washington, D.C.: American Society for Microbiology, 1993:563-72.
Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239. [ISI][Medline]
Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991;29:2240-2244. [Free Full Text]
Wallenstein S. A non-iterative accurate asymptotic confidence interval for the difference between two proportions. Stat Med 1997;16:1329-1336. [CrossRef][ISI][Medline]
Shuter J, Hatcher VB, Lowy FD. Staphylococcus aureus binding to human nasal mucin. Infect Immun 1996;64:310-318. [Abstract]
VandenBergh MF, Yzerman EP, van Belkum A, Boelens HA, Sijmons M, Verbrugh HA. Follow-up of Staphylococcus aureus nasal carriage after8 years: redefining the persistent carrier state. J Clin Microbiol 1999;37:3133-3140. [Free Full Text]
Casewell MW, Hill RL. The carrier state: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1986;18:Suppl A:1-12. [Free Full Text]
Armstrong-Esther CA. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol 1976;3:221-227. [CrossRef][Medline]
Mest DR, Wong DH, Shimoda KJ, Mulligan ME, Wilson SE. Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection. Anesth Analg 1994;78:644-650. [Free Full Text]
Weinke T, Schiller R, Fehrenbach FJ, Pohle HD. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1992;11:985-989. [CrossRef][ISI][Medline]
Ena J, Boelaert JR, Boyken LD, Van Landuyt HW, Godard CA, Herwaldt LA. Epidemiology of Staphylococcus aureus infections in patients on hemodialysis. Infect Control Hosp Epidemiol 1994;15:78-81. [ISI][Medline]
Luzar MA. Exit-site infection in continuous ambulatory peritoneal dialysis: a review. Perit Dial Int 1991;11:333-340.
Pujol M, Pena C, Pallares R, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996;100:509-516. [CrossRef][ISI][Medline]
Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998;18:261-270. [Free Full Text]
Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991;114:101-106.
Boelaert JR, Van Landuyt HW, Gordts BZ, De Baere YA, Messer SA, Herwaldt LA. Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: the effect of nasal mupirocin. Infect Control Hosp Epidemiol 1996;17:809-811. [ISI][Medline]
Parras F, Guerrero MC, Bouza E, et al. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995;39:175-179. [Abstract]
Fierobe L, Decre D, Muller C, et al. Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization. Clin Infect Dis 1999;29:1231-1238. [CrossRef][ISI][Medline]
Nguyen MH, Kauffman CA, Goodman RP, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999;130:221-225. [Free Full Text]
Tenover FC, Arbeit RD, Goering RV. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Infect Control Hosp Epidemiol 1997;18:426-439. [ISI][Medline]
Tenover FC, Arbeit R, Archer G, et al. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus. J Clin Microbiol 1994;32:407-415. [Free Full Text]
Appendix
In addition to the authors, the following were participantsin the study group: D. Bitter-Suermann, Hannover; W. Ehret,Augsburg; P. Emmerling, Munich; F. Fehrenbach, Berlin; H. Finger,Krefeld; H. Freiesleben, Hamburg; D. Fritsche, Ludwigshafen;H. Hahn, Berlin; J. Heesemann, Munich; U. Hoeffler, Düsseldorf;H.-M. Just, Nuremberg; E. Kühnen, Trier; H. Langmaack,Berlin; R. Laufs, Hamburg; R. Lütticken, Aachen; R. Marre,Ulm; W.A. Müller, Magdeburg; B. Neuhaus, Münster;M. Röllinghoff, Erlangen; G. Ruckdeschel, Munich; J. Sander,Hannover; G. Schroeter, Stuttgart; P. Shah, Frankfurt; W. Sietzen,Hamburg; H.G. Sonntag, Heidelberg; E. Straube, Jena; R. Tauchnitz,Leipzig; U. Ullmann, Kiel; H. Werner, Tübingen; H. Wolf,Regensburg; and P. Wutzler, Erfurt all in Germany.
Severin, J. A., Lestari, E. S., Kuntaman, K., Melles, D. C., Pastink, M., Peeters, J. K., Snijders, S. V., Hadi, U., Duerink, D. O., van Belkum, A., Verbrugh, H. A., on behalf of the Antimicrobial Resistance in Indon,
(2008). Unusually High Prevalence of Panton-Valentine Leukocidin Genes among Methicillin-Sensitive Staphylococcus aureus Strains Carried in the Indonesian Population. J. Clin. Microbiol.
46: 1989-1995
[Abstract][Full Text]
Nathwani, D., Morgan, M., Masterton, R. G., Dryden, M., Cookson, B. D., French, G., Lewis, D., on behalf of the British Society for Antimicrobial,
(2008). Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother
61: 976-994
[Abstract][Full Text]
Lu, P.-L., Tsai, J.-C., Chiu, Y.-W., Chang, F.-Y., Chen, Y.-W., Hsiao, C.-F., Siu, L. K.
(2008). Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant
23: 1659-1665
[Abstract][Full Text]
Koprivnjak, T., Weidenmaier, C., Peschel, A., Weiss, J. P.
(2008). Wall Teichoic Acid Deficiency in Staphylococcus aureus Confers Selective Resistance to Mammalian Group IIA Phospholipase A2 and Human {beta}-Defensin 3. Infect. Immun.
76: 2169-2176
[Abstract][Full Text]
Al-Rawahi, G. N., Schreader, A. G., Porter, S. D., Roscoe, D. L., Gustafson, R., Bryce, E. A.
(2008). Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later. J. Clin. Microbiol.
46: 477-479
[Abstract][Full Text]
Robicsek, A., Suseno, M., Beaumont, J. L., Thomson, R. B. Jr., Peterson, L. R.
(2008). Prediction of Methicillin-Resistant Staphylococcus aureus Involvement in Disease Sites by Concomitant Nasal Sampling. J. Clin. Microbiol.
46: 588-592
[Abstract][Full Text]
Hussain, M., von Eiff, C., Sinha, B., Joost, I., Herrmann, M., Peters, G., Becker, K.
(2008). eap Gene as Novel Target for Specific Identification of Staphylococcus aureus. J. Clin. Microbiol.
46: 470-476
[Abstract][Full Text]
van Rijen, M. M. L., Bonten, M., Wenzel, R. P., Kluytmans, J. A. J. W.
(2008). Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother
61: 254-261
[Abstract][Full Text]
Sendi, P., Bregenzer, T., Zimmerli, W.
(2008). Spinal epidural abscess in clinical practice. QJM
101: 1-12
[Abstract][Full Text]
Huang, Y.-C., Hwang, K.-P., Chen, P.-Y., Chen, C.-J., Lin, T.-Y.
(2007). Prevalence of Methicillin-Resistant Staphylococcus aureus Nasal Colonization among Taiwanese Children in 2005 and 2006. J. Clin. Microbiol.
45: 3992-3995
[Abstract][Full Text]
Stapleton, M. R., Horsburgh, M. J., Hayhurst, E. J., Wright, L., Jonsson, I.-M., Tarkowski, A., Kokai-Kun, J. F., Mond, J. J., Foster, S. J.
(2007). Characterization of IsaA and SceD, Two Putative Lytic Transglycosylases of Staphylococcus aureus. J. Bacteriol.
189: 7316-7325
[Abstract][Full Text]
Patel, M., Kumar, R. A., Stamm, A. M., Hoesley, C. J., Moser, S. A., Waites, K. B.
(2007). USA300 Genotype Community-Associated Methicillin-Resistant Staphylococcus aureus as a Cause of Surgical Site Infections. J. Clin. Microbiol.
45: 3431-3433
[Abstract][Full Text]
Ellis, M. W., Griffith, M. E., Dooley, D. P., McLean, J. C., Jorgensen, J. H., Patterson, J. E., Davis, K. A., Hawley, J. S., Regules, J. A., Rivard, R. G., Gray, P. J., Ceremuga, J. M., DeJoseph, M. A., Hospenthal, D. R.
(2007). Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial. Antimicrob. Agents Chemother.
51: 3591-3598
[Abstract][Full Text]
San Juan, R., Chaves, F., Lopez Gude, M. J., Diaz-Pedroche, C., Otero, J., Cortina Romero, J. M., Rufilanchas, J. J., Aguado, J. M.
(2007). Staphylococcus aureus poststernotomy mediastinitis: Description of two distinct acquisition pathways with different potential preventive approaches. J. Thorac. Cardiovasc. Surg.
134: 670-676
[Abstract][Full Text]
Paule, S. M., Hacek, D. M., Kufner, B., Truchon, K., Thomson, R. B. Jr., Kaul, K. L., Robicsek, A., Peterson, L. R.
(2007). Performance of the BD GeneOhm Methicillin-Resistant Staphylococcus aureus Test before and during High-Volume Clinical Use. J. Clin. Microbiol.
45: 2993-2998
[Abstract][Full Text]
Ridder-Schaphorn, S., Ratjen, F., Dubbers, A., Haberle, J., Falk, S., Kuster, P., Schuster, A., Mellies, U., Lowe, B., Reintjes, R., Peters, G., Kahl, B. C.
(2007). Nasal Staphylococcus aureus Carriage Is Not a Risk Factor for Lower-Airway Infection in Young Cystic Fibrosis Patients. J. Clin. Microbiol.
45: 2979-2984
[Abstract][Full Text]
Holtfreter, S., Grumann, D., Schmudde, M., Nguyen, H. T. T., Eichler, P., Strommenger, B., Kopron, K., Kolata, J., Giedrys-Kalemba, S., Steinmetz, I., Witte, W., Broker, B. M.
(2007). Clonal Distribution of Superantigen Genes in Clinical Staphylococcus aureus Isolates. J. Clin. Microbiol.
45: 2669-2680
[Abstract][Full Text]
Baranwal, A. K., Singhi, S. C., Jayashree, M.
(2007). A 5-year PICU Experience of Disseminated Staphylococcal Disease, Part 1: Clinical and Microbial Profile. J Trop Pediatr
53: 245-251
[Abstract][Full Text]
Daum, R. S.
(2007). Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus. NEJM
357: 380-390
[Full Text]
Melles, D. C., Bogaert, D., Gorkink, R. F. J., Peeters, J. K., Moorhouse, M. J., Ott, A., van Leeuwen, W. B., Simons, G., Verbrugh, H. A., Hermans, P. W. M., van Belkum, A.
(2007). Nasopharyngeal co-colonization with Staphylococcus aureus and Streptococcus pneumoniae in children is bacterial genotype independent. Microbiology
153: 686-692
[Abstract][Full Text]
Duval, X., Alla, F., Doco-Lecompte, T., Le Moing, V., Delahaye, F., Mainardi, J.-L., Plesiat, P., Celard, M., Hoen, B., Leport, C., for the Association pour l'Etude et la Prevention,
(2007). Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality. Eur Heart J
28: 59-64
[Abstract][Full Text]
Falagas, M. E., Fragoulis, K. N., Bliziotis, I. A.
(2006). Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure--a meta-analysis of randomized controlled trials. Nephrol Dial Transplant
21: 2536-2542
[Abstract][Full Text]
Huang, Y.-C., Chou, Y.-H., Su, L.-H., Lien, R.-I., Lin, T.-Y.
(2006). Methicillin-Resistant Staphylococcus aureus Colonization and Its Association With Infection Among Infants Hospitalized in Neonatal Intensive Care Units. Pediatrics
118: 469-474
[Abstract][Full Text]
Shrestha, N. K., Banbury, M. K., Weber, M., Cwynar, R. E., Lober, C., Procop, G. W., Karafa, M. T., Gordon, S. M.
(2006). Safety of Targeted Perioperative Mupirocin Treatment for Preventing Infections After Cardiac Surgery. Ann. Thorac. Surg.
81: 2183-2188
[Abstract][Full Text]
Hunt, C. L., Nauseef, W. M., Weiss, J. P.
(2006). Effect of D-Alanylation of (Lipo)Teichoic Acids of Staphylococcus aureus on Host Secretory Phospholipase A2 Action before and after Phagocytosis by Human Neutrophils.. J. Immunol.
176: 4987-4994
[Abstract][Full Text]
Schaffer, A. C., Solinga, R. M., Cocchiaro, J., Portoles, M., Kiser, K. B., Risley, A., Randall, S. M., Valtulina, V., Speziale, P., Walsh, E., Foster, T., Lee, J. C.
(2006). Immunization with Staphylococcus aureus Clumping Factor B, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model. Infect. Immun.
74: 2145-2153
[Abstract][Full Text]
Borysowski, J., Weber-Dabrowska, B., Gorski, A.
(2006). Bacteriophage endolysins as a novel class of antibacterial agents.. Exp. Biol. Med.
231: 366-377
[Abstract][Full Text]
Graham, P. L. III, Lin, S. X., Larson, E. L.
(2006). A U.S. population-based survey of Staphylococcus aureus colonization.. ANN INTERN MED
144: 318-325
[Abstract][Full Text]
Mainous, A. G. III, Hueston, W. J., Everett, C. J., Diaz, V. A.
(2006). Nasal Carriage of Staphylococcus aureus and Methicillin-Resistant S aureus in the United States, 2001-2002. Ann Fam Med
4: 132-137
[Abstract][Full Text]
Stoakes, L., Reyes, R., Daniel, J., Lennox, G., John, M. A., Lannigan, R., Hussain, Z.
(2006). Prospective Comparison of a New Chromogenic Medium, MRSASelect, to CHROMagar MRSA and Mannitol-Salt Medium Supplemented with Oxacillin or Cefoxitin for Detection of Methicillin-Resistant Staphylococcus aureus. J. Clin. Microbiol.
44: 637-639
[Abstract][Full Text]
Rajagopalan, G., Iijima, K., Singh, M., Kita, H., Patel, R., David, C. S.
(2006). Intranasal Exposure to Bacterial Superantigens Induces Airway Inflammation in HLA Class II Transgenic Mice. Infect. Immun.
74: 1284-1296
[Abstract][Full Text]
Becker, K., Pagnier, I., Schuhen, B., Wenzelburger, F., Friedrich, A. W., Kipp, F., Peters, G., von Eiff, C.
(2006). Does Nasal Cocolonization by Methicillin-Resistant Coagulase-Negative Staphylococci and Methicillin-Susceptible Staphylococcus aureus Strains Occur Frequently Enough To Represent a Risk of False-Positive Methicillin-Resistant S. aureus Determinations by Molecular Methods?. J. Clin. Microbiol.
44: 229-231
[Abstract][Full Text]
Critchley, I. A., Young, C. L., Stone, K. C., Ochsner, U. A., Guiles, J., Tarasow, T., Janjic, N.
(2005). Antibacterial Activity of REP8839, a New Antibiotic for Topical Use. Antimicrob. Agents Chemother.
49: 4247-4252
[Abstract][Full Text]
Rouse, M. S., Rotger, M., Piper, K. E., Steckelberg, J. M., Scholz, M., Andrews, J., Patel, R.
(2005). In Vitro and In Vivo Evaluations of the Activities of Lauric Acid Monoester Formulations against Staphylococcus aureus. Antimicrob. Agents Chemother.
49: 3187-3191
[Abstract][Full Text]
Rotger, M., Trampuz, A., Piper, K. E., Steckelberg, J. M., Patel, R.
(2005). Phenotypic and Genotypic Mupirocin Resistance among Staphylococci Causing Prosthetic Joint Infection. J. Clin. Microbiol.
43: 4266-4268
[Abstract][Full Text]
Blickwede, M., Goethe, R., Wolz, C., Valentin-Weigand, P., Schwarz, S.
(2005). Molecular basis of florfenicol-induced increase in adherence of Staphylococcus aureus strain Newman. J Antimicrob Chemother
56: 315-323
[Abstract][Full Text]
Issartel, B., Tristan, A., Lechevallier, S., Bruyere, F., Lina, G., Garin, B., Lacassin, F., Bes, M., Vandenesch, F., Etienne, J.
(2005). Frequent Carriage of Panton-Valentine Leucocidin Genes by Staphylococcus aureus Isolates from Surgically Drained Abscesses. J. Clin. Microbiol.
43: 3203-3207
[Abstract][Full Text]
Corne, P., Marchandin, H., Jonquet, O., Campos, J., Banuls, A.-L.
(2005). Molecular Evidence that Nasal Carriage of Staphylococcus aureus Plays a Role in Respiratory Tract Infections of Critically Ill Patients. J. Clin. Microbiol.
43: 3491-3493
[Abstract][Full Text]
Giannoudis, P. V., Parker, J., Wilcox, M. H.
(2005). Methicillin-resistant Staphylococcus aureus in trauma and orthopaedic practice. J Bone Joint Surg Br
87-B: 749-754
[Full Text]
Wertheim, H. F. L., Verveer, J., Boelens, H. A. M., van Belkum, A., Verbrugh, H. A., Vos, M. C.
(2005). Effect of Mupirocin Treatment on Nasal, Pharyngeal, and Perineal Carriage of Staphylococcus aureus in Healthy Adults. Antimicrob. Agents Chemother.
49: 1465-1467
[Abstract][Full Text]
Karaolis, D. K. R., Rashid, M. H., Chythanya, R., Luo, W., Hyodo, M., Hayakawa, Y.
(2005). c-di-GMP (3'-5'-Cyclic Diguanylic Acid) Inhibits Staphylococcus aureus Cell-Cell Interactions and Biofilm Formation. Antimicrob. Agents Chemother.
49: 1029-1038
[Abstract][Full Text]
Gonzalez-Zorn, B., Senna, J. P. M., Fiette, L., Shorte, S., Testard, A., Chignard, M., Courvalin, P., Grillot-Courvalin, C.
(2005). Bacterial and Host Factors Implicated in Nasal Carriage of Methicillin-Resistant Staphylococcus aureus in Mice. Infect. Immun.
73: 1847-1851
[Abstract][Full Text]
Lu, P.-L., Chin, L.-C., Peng, C.-F., Chiang, Y.-H., Chen, T.-P., Ma, L., Siu, L. K
(2005). Risk Factors and Molecular Analysis of Community Methicillin-Resistant Staphylococcus aureus Carriage. J. Clin. Microbiol.
43: 132-139
[Abstract][Full Text]
Walsh, E. J., O'Brien, L. M., Liang, X., Hook, M., Foster, T. J.
(2004). Clumping Factor B, a Fibrinogen-binding MSCRAMM (Microbial Surface Components Recognizing Adhesive Matrix Molecules) Adhesin of Staphylococcus aureus, Also Binds to the Tail Region of Type I Cytokeratin 10. J. Biol. Chem.
279: 50691-50699
[Abstract][Full Text]
Warner, J. E., Onderdonk, A. B.
(2004). Diversity of Toxic Shock Syndrome Toxin 1-Positive Staphylococcus aureus Isolates. Appl. Environ. Microbiol.
70: 6931-6935
[Abstract][Full Text]
Nouwen, J., Boelens, H., van Belkum, A., Verbrugh, H.
(2004). Human Factor in Staphylococcus aureus Nasal Carriage. Infect. Immun.
72: 6685-6688
[Abstract][Full Text]
Becker, K., Harmsen, D., Mellmann, A., Meier, C., Schumann, P., Peters, G., von Eiff, C.
(2004). Development and Evaluation of a Quality-Controlled Ribosomal Sequence Database for 16S Ribosomal DNA-Based Identification of Staphylococcus Species. J. Clin. Microbiol.
42: 4988-4995
[Abstract][Full Text]
Kruszewska, D., Sahl, H.-G., Bierbaum, G., Pag, U., Hynes, S. O., Ljungh, A.
(2004). Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother
54: 648-653
[Abstract][Full Text]
Regev-Yochay, G., Dagan, R., Raz, M., Carmeli, Y., Shainberg, B., Derazne, E., Rahav, G., Rubinstein, E.
(2004). Association Between Carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children. JAMA
292: 716-720
[Abstract][Full Text]
Paule, S. M., Pasquariello, A. C., Hacek, D. M., Fisher, A. G., Thomson, R. B. Jr, Kaul, K. L., Peterson, L. R.
(2004). Direct Detection of Staphylococcus aureus from Adult and Neonate Nasal Swab Specimens Using Real-Time Polymerase Chain Reaction. J. Mol. Diagn.
6: 191-196
[Abstract][Full Text]
Holtfreter, S., Bauer, K., Thomas, D., Feig, C., Lorenz, V., Roschack, K., Friebe, E., Selleng, K., Lovenich, S., Greve, T., Greinacher, A., Panzig, B., Engelmann, S., Lina, G., Broker, B. M.
(2004). egc-Encoded Superantigens from Staphylococcus aureus Are Neutralized by Human Sera Much Less Efficiently than Are Classical Staphylococcal Enterotoxins or Toxic Shock Syndrome Toxin. Infect. Immun.
72: 4061-4071
[Abstract][Full Text]
Lockhart, P. B., Brennan, M. T., Kent, M. L., Norton, H. J., Weinrib, D. A.
(2004). Impact of Amoxicillin Prophylaxis on the Incidence, Nature, and Duration of Bacteremia in Children After Intubation and Dental Procedures. Circulation
109: 2878-2884
[Abstract][Full Text]
Ladhani, S, Konana, O S, Mwarumba, S, English, M C
(2004). Bacteraemia due to Staphylococcus aureus. Arch. Dis. Child.
89: 568-571
[Abstract][Full Text]
Wertheim, H. F.L., Vos, M. C., Ott, A., Voss, A., Kluytmans, J. A.J.W., Vandenbroucke-Grauls, C. M.J.E., Meester, M. H.M., van Keulen, P. H.J., Verbrugh, H. A.
(2004). Mupirocin Prophylaxis against Nosocomial Staphylococcus aureus Infections in Nonsurgical Patients: A Randomized Study. ANN INTERN MED
140: 419-425
[Abstract][Full Text]
Chambers, H. F. III, Winston, L. G.
(2004). Mupirocin Prophylaxis Misses by a Nose. ANN INTERN MED
140: 484-485
[Full Text]
Jin, T., Bokarewa, M., Foster, T., Mitchell, J., Higgins, J., Tarkowski, A.
(2004). Staphylococcus aureus Resists Human Defensins by Production of Staphylokinase, a Novel Bacterial Evasion Mechanism. J. Immunol.
172: 1169-1176
[Abstract][Full Text]
Saiman, L., Siegel, J.
(2004). Infection Control in Cystic Fibrosis. Clin. Microbiol. Rev.
17: 57-71
[Abstract][Full Text]
Harmsen, D., Claus, H., Witte, W., Rothganger, J., Claus, H., Turnwald, D., Vogel, U.
(2003). Typing of Methicillin-Resistant Staphylococcus aureus in a University Hospital Setting by Using Novel Software for spa Repeat Determination and Database Management. J. Clin. Microbiol.
41: 5442-5448
[Abstract][Full Text]
Peacock, S. J., Justice, A., Griffiths, D., de Silva, G. D. I., Kantzanou, M. N., Crook, D., Sleeman, K., Day, N. P. J.
(2003). Determinants of Acquisition and Carriage of Staphylococcus aureus in Infancy. J. Clin. Microbiol.
41: 5718-5725
[Abstract][Full Text]
von Eiff, C., Kokai-Kun, J. F., Becker, K., Peters, G.
(2003). In Vitro Activity of Recombinant Lysostaphin against Staphylococcus aureus Isolates from Anterior Nares and Blood. Antimicrob. Agents Chemother.
47: 3613-3615
[Abstract][Full Text]
Kahl, B. C., Becker, K., Friedrich, A. W., Clasen, J., Sinha, B., von Eiff, C., Peters, G.
(2003). agr-Dependent Bacterial Interference Has No Impact on Long-Term Colonization of Staphylococcus aureus during Persistent Airway Infection of Cystic Fibrosis Patients. J. Clin. Microbiol.
41: 5199-5201
[Abstract][Full Text]
Jin, T., Bokarewa, M., McIntyre, L., Tarkowski, A., Corey, G. R., Reller, L. B., Fowler, V. G. Jr
(2003). Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol
52: 919-923
[Abstract][Full Text]
Singh, K., Gavin, P. J., Vescio, T., Thomson, R. B. Jr., Deddish, R. B., Fisher, A., Noskin, G. A., Peterson, L. R.
(2003). Microbiologic Surveillance Using Nasal Cultures Alone Is Sufficient for Detection of Methicillin-Resistant Staphylococcus aureus Isolates in Neonates. J. Clin. Microbiol.
41: 2755-2757
[Abstract][Full Text]
Holman, W. L., Rayburn, B. K., McGiffin, D. C., Foley, B. A., Benza, R. L., Bourge, R. C., Pinderski, L. J., Kirklin, J. K.
(2003). Infection in ventricular assist devices: prevention and treatment. Ann. Thorac. Surg.
75: S48-57
[Abstract][Full Text]
Kokai-Kun, J. F., Walsh, S. M., Chanturiya, T., Mond, J. J.
(2003). Lysostaphin Cream Eradicates Staphylococcus aureus Nasal Colonization in a Cotton Rat Model. Antimicrob. Agents Chemother.
47: 1589-1597
[Abstract][Full Text]
Decousser, J.-W., Pina, P., Picot, F., Delalande, C., Pangon, B., Courvalin, P., Allouch, P., the ColBVH study group,
(2003). Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey. J Antimicrob Chemother
51: 1213-1222
[Abstract][Full Text]
Becker, K., Friedrich, A. W., Lubritz, G., Weilert, M., Peters, G., von Eiff, C.
(2003). Prevalence of Genes Encoding Pyrogenic Toxin Superantigens and Exfoliative Toxins among Strains of Staphylococcus aureus Isolated from Blood and Nasal Specimens. J. Clin. Microbiol.
41: 1434-1439
[Abstract][Full Text]
Khatib, R., Sharma, M., Naqvi, S. A. H., Riederer, K., Almoujahed, M. O., Fakih, M. G.
(2003). Molecular Analysis of Staphylococcus aureus Blood Isolates Shows Lack of Polyclonal Bacteremia. J. Clin. Microbiol.
41: 1717-1719
[Abstract][Full Text]
Gluck, U., Gebbers, J.-O.
(2003). Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and {beta}-hemolytic streptococci). Am. J. Clin. Nutr.
77: 517-520
[Abstract][Full Text]
Jones, C.
(2003). An Infant in Septic Shock. CLIN PEDIATR
42: 85-87
O'Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., Raad, I. I., Randolph, A., Weinstein, R. A.
(2002). Guidelines for the Prevention of Intravascular Catheter-Related Infections. Pediatrics
110: e51-51
[Abstract][Full Text]
von Eiff, C., Kipp, F., Becker, K., Delgado-Hachmeister, J. E., Graviss, E. A., Perl, T. M., Zimmerman, M. B.
(2002). Intranasal Mupirocin to Prevent Postoperative Infections. NEJM
347: 1207-1208
[Full Text]
Peacock, S. J., de Silva, G. D. I., Justice, A., Cowland, A., Moore, C. E., Winearls, C. G., Day, N. P. J.
(2002). Comparison of Multilocus Sequence Typing and Pulsed-Field Gel Electrophoresis as Tools for Typing Staphylococcus aureus Isolates in a Microepidemiological Setting. J. Clin. Microbiol.
40: 3764-3770
[Abstract][Full Text]
Cespedes, C., Miller, M., Quagliarello, B., Vavagiakis, P., Klein, R. S., Lowy, F. D.
(2002). Differences between Staphylococcus aureus Isolates from Medical and Nonmedical Hospital Personnel. J. Clin. Microbiol.
40: 2594-2597
[Abstract][Full Text]
Perl, T. M., Cullen, J. J., Wenzel, R. P., Zimmerman, M. B., Pfaller, M. A., Sheppard, D., Twombley, J., French, P. P., Herwaldt, L. A., the Mupirocin and the Risk of Staphylococcus aureu,
(2002). Intranasal Mupirocin to Prevent Postoperative Staphylococcus aureus Infections. NEJM
346: 1871-1877
[Abstract][Full Text]
Hussain, M., Haggar, A., Heilmann, C., Peters, G., Flock, J.-I., Herrmann, M.
(2002). Insertional Inactivation of eap in Staphylococcus aureus Strain Newman Confers Reduced Staphylococcal Binding to Fibroblasts. Infect. Immun.
70: 2933-2940
[Abstract][Full Text]
Chastre, J., Fagon, J.-Y.
(2002). Ventilator-associated Pneumonia. Am. J. Respir. Crit. Care Med.
165: 867-903
[Abstract][Full Text]
von Eiff, C., Peters, G.
(2002). Comparative in vitro activity of ABT-773 and two macrolides against staphylococci. J Antimicrob Chemother
49: 189-192
[Abstract][Full Text]
Carrier, M., Marchand, R., Auger, P., Hebert, Y., Pellerin, M., Perrault, L. P., Cartier, R., Bouchard, D., Poirier, N., Page, P.
(2002). Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. J. Thorac. Cardiovasc. Surg.
123: 40-44
[Abstract][Full Text]
HAYON, J., FIGLIOLINI, C., COMBES, A., TROUILLET, J.-L., KASSIS, N., DOMBRET, M. C., GIBERT, C., CHASTRE, J.
(2002). Role of Serial Routine Microbiologic Culture Results in the Initial Management of Ventilator-associated Pneumonia. Am. J. Respir. Crit. Care Med.
165: 41-46
[Abstract][Full Text]
Hussain, M., Becker, K., von Eiff, C., Schrenzel, J., Peters, G., Herrmann, M.
(2001). Identification and Characterization of a Novel 38.5-Kilodalton Cell Surface Protein of Staphylococcus aureus with Extended-Spectrum Binding Activity for Extracellular Matrix and Plasma Proteins. J. Bacteriol.
183: 6778-6786
[Abstract][Full Text]
Osmon, D. R.
(2001). Antimicrobial Resistance: Guidelines for the Practicing Orthopaedic Surgeon. JBJS
83: 1891-1901
[Full Text]
Cole, A. M., Tahk, S., Oren, A., Yoshioka, D., Kim, Y.-H., Park, A., Ganz, T.
(2001). Determinants of Staphylococcusaureus Nasal Carriage. CVI
8: 1064-1069
[Abstract][Full Text]
Hussain, M., Becker, K., von Eiff, C., Peters, G., Herrmann, M.
(2001). Analogs of Eap Protein Are Conserved and Prevalent in Clinical Staphylococcus aureus Isolates. CVI
8: 1271-1276
[Abstract][Full Text]
van Belkum, A., Verbrugh, H.
(2001). 40 years of methicillin resistant Staphylococcus aureus. BMJ
323: 644-645
[Full Text]
Gluck, U., Lecomte, F., Nouvellon, M., Levesque, H., Johnson, J. R., Harbarth, S., Gundlapalli, A. V., Samore, M. H., von Eiff, C., Becker, K., Peters, G.
(2001). Nasal Carriage of Staphylococcus aureus. NEJM
344: 1399-1401
[Full Text]
(2001). The Nose Knows: The Anterior Nares as the Source of Staphylococcus aureus Bacteremia. JWatch Emergency Med.
2001: 4-4
[Full Text]
(2001). Staph Moves from Nose to Blood. JWatch General
2001: 3-3
[Full Text]
(2001). Where Does Staph Come From? The Nose Knows!. JWatch Infect. Diseases
2001: 13-13
[Full Text]
Archer, G. L., Climo, M. W.
(2001). Staphylococcus aureus Bacteremia -- Consider the Source. NEJM
344: 55-56
[Full Text]
Nelson, D., Loomis, L., Fischetti, V. A.
(2001). Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc. Natl. Acad. Sci. USA
98: 4107-4112
[Abstract][Full Text]